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serum samples was performed according to the WHO stan-
dard method.
Results: 9 of 13 isolates in type 1, 23 of 25 isolates in
type 2 and 16 of 29 isolates in type 3 were virulent VDPVs.
Seropositivities against the virulent type 1 and 2 VDPVs were
more than 90%, but the values against the virulent type 3
VDPVs were approximately 60%. Also, neutralizing antibody
titers against the virulent type 3 VDPVs were the lowest in
comparison with the titers against the virulent type 1 and 2
VDPVs.
Conclusion: Our results suggest that Japan’s vaccination
policy, a 2-dose administration of OPV, might be enough to
prevent an epidemic of poliomyelitis caused by virulent type
1, 2 and 3 VDPVs, even though the seropositivity and anti-
body titers against type 3 viruses were the lowest. However,
a booster dose of the vaccine for the type 3 virus is recom-
mended.
doi:10.1016/j.ijid.2008.05.353
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Background: Epidemic inﬂuenza causes serious mortal-
ity and morbidity in temperate, subtropical, and tropical
countries annually. Recent studies show that school-age chil-
dren are the major spreaders of inﬂuenza transmission,
and also strong evidences prove that vaccinating schoolchil-
dren against inﬂuenza is the cost-effective way to reduce
inﬂuenza-related morbidity among children and their house-
holds. Thus, Taiwan CDC has decided to provide the ﬂu shots
focusing on ﬁrst and second grade students in the entire
country since November 1, 2007. The aims of this pilot study
were to assess the feasibility of a school-based inﬂuenza
vaccination program and to evaluate the impacts on the
households.
Methods: During fall 2007, we recruited 8 elementary
schools from four counties/cities including 4 intervention
schools assigned to vaccinate all students and 4 control
schools only on ﬁrst and second grade students. Writ-
ten informed consent was obtained from the parents of
the children who participated in this study. All house-
holds with children included in this study were surveyed
by a weekly diary to record inﬂuenza-like illness (ILI).
School nurses were trained to collect a small validation
set of throat swabs from the children with acute ILI
symptoms.
Results: There were 3,784 students (57% of the 6,671
students in 8 schools) participating in this study. The vac-
cine coverage for the intervention and control schools were
45% and 19% respectively. By February 1 2008, 96 throat
swabs had been collected, and 6 of them were positive for
inﬂuenza virus. Since the study is still ongoing, the weekly
diary and throat swabs will be collected until the end of
April, 2008. Further results for the impacts on the house-
holds will be analyzed and discussed later.
Conclusion: Lessons learned from this pilot study will
provide further guidance for evaluating the school-based
inﬂuenza vaccination study in 2008-2009 season.
doi:10.1016/j.ijid.2008.05.354
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Introduction: The elderly, despite being most at risk for
invasive pneumococcal disease, respond poorly to polysac-
charide vaccine. Conjugated vaccine technology overcomes
this problem in children aged <2 years, but conjugated vac-
cines are not licensed for use in adults. Clinical predictors
of response to vaccines other than chronological age may
assist in targeting adults in most need of a more immuno-
genic vaccine. An index of frailty (FI) has gained support as a
measurement tool, but has not been examined as a predictor
of immune responsiveness.
Aims: To determine the response to 23 valent polysac-
charide (PPV) and 7-valent conjugate (PCV7) pneumococcal
vaccines in the elderly by level of frailty.
Methods: A randomized controlled clinical trial of hos-
pitalized elderly was conducted. Subjects were randomised
to receive PPV or PCV7; those who received PCV7 received
PPV 6 months later. Serology was measured by enzyme
immunoassay (ELISA) against four serotypes, 4, 6B, 18C and
19F.
Results: For all four sero types there were statisti-
cally signiﬁcant increases in geometric mean concentrations
after immunization; however there were no difference
between 23PPV and PCV7. There association between frailty
scores and geometric mean concentrations (GMC) varied
by serotype. For serotype 4, there was a clear relation-
ship between response and frailty - responses decreased
with increasing frailty. This relationship was seen to a lesser
degree for serotypes 18C and 19F. Type 6B is considered to
be a poor immunogenic and there were very little change in
both groups from baseline to 6 months.
Conclusions: We demonstrated the more frail patients
had a poorer immune response to polysaccharide and conju-
gate pneumococcal vaccines, except for serotype 6B, where
responses were poor in all groups. The use of a frailty index
may be more suitable than age alone to determine people
at risk of poor vaccine responses.
doi:10.1016/j.ijid.2008.05.355
